News coverage about Select Medical (NYSE:SEM) has trended somewhat positive recently, Accern reports. Accern identifies negative and positive media coverage by monitoring more than twenty million blog and news sources. Accern ranks coverage of public companies on a scale of negative one to positive one, with scores nearest to one being the most favorable. Select Medical earned a media sentiment score of 0.18 on Accern’s scale. Accern also gave news articles about the health services provider an impact score of 45.7652932414752 out of 100, indicating that recent media coverage is somewhat unlikely to have an impact on the stock’s share price in the next several days.

Several equities research analysts have recently weighed in on SEM shares. Deutsche Bank reaffirmed a “buy” rating and issued a $22.00 price target on shares of Select Medical in a research report on Monday, November 6th. ValuEngine raised shares of Select Medical from a “hold” rating to a “buy” rating in a research report on Sunday, December 31st. Robert W. Baird set a $25.00 target price on shares of Select Medical and gave the company a “buy” rating in a research report on Monday, October 23rd. Royal Bank of Canada reissued a “buy” rating and set a $19.00 target price on shares of Select Medical in a research report on Friday, October 13th. Finally, Zacks Investment Research cut shares of Select Medical from a “buy” rating to a “hold” rating in a research report on Tuesday, October 10th. One investment analyst has rated the stock with a sell rating, four have issued a hold rating and five have issued a buy rating to the company’s stock. The stock presently has an average rating of “Hold” and a consensus target price of $19.43.

Shares of Select Medical (SEM) opened at $17.35 on Friday. Select Medical has a 52-week low of $12.00 and a 52-week high of $19.77. The company has a debt-to-equity ratio of 3.36, a quick ratio of 1.51 and a current ratio of 1.51. The company has a market cap of $2,320.00, a P/E ratio of 24.10, a P/E/G ratio of 1.11 and a beta of 1.34.

Select Medical (NYSE:SEM) last posted its earnings results on Thursday, November 2nd. The health services provider reported $0.14 EPS for the quarter, missing the Zacks’ consensus estimate of $0.16 by ($0.02). Select Medical had a net margin of 2.21% and a return on equity of 11.44%. The firm had revenue of $1.10 billion for the quarter, compared to analysts’ expectations of $1.10 billion. During the same period in the previous year, the company earned $0.06 EPS. The company’s revenue was up 4.1% on a year-over-year basis. equities analysts forecast that Select Medical will post 0.86 EPS for the current fiscal year.

In other Select Medical news, insider Michael E. Tarvin sold 18,500 shares of the company’s stock in a transaction that occurred on Monday, October 30th. The shares were sold at an average price of $18.97, for a total transaction of $350,945.00. Following the transaction, the insider now owns 340,044 shares in the company, valued at approximately $6,450,634.68. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Also, insider Martin F. Jackson sold 134,029 shares of the company’s stock in a transaction that occurred on Friday, December 22nd. The shares were sold at an average price of $17.05, for a total transaction of $2,285,194.45. Following the transaction, the insider now owns 1,717,944 shares in the company, valued at approximately $29,290,945.20. The disclosure for this sale can be found here. Insiders have sold 314,455 shares of company stock valued at $5,403,144 in the last three months. 19.93% of the stock is currently owned by corporate insiders.

ILLEGAL ACTIVITY WARNING: “Somewhat Favorable Media Coverage Somewhat Unlikely to Impact Select Medical (SEM) Stock Price” was published by Watch List News and is owned by of Watch List News. If you are accessing this piece of content on another domain, it was stolen and reposted in violation of international copyright & trademark laws. The correct version of this piece of content can be accessed at https://www.watchlistnews.com/somewhat-favorable-media-coverage-somewhat-unlikely-to-impact-select-medical-sem-stock-price/1813218.html.

Select Medical Company Profile

Select Medical Holdings Corporation is an operator of specialty hospitals, outpatient rehabilitation clinics and occupational medicine centers in the United States. The Company’s segments include specialty hospitals, outpatient rehabilitation, Concentra and Other. The specialty hospitals segment consists of hospitals designed to serve the needs of long term acute patients and hospitals designed to serve patients that require intensive medical rehabilitation care.

Insider Buying and Selling by Quarter for Select Medical (NYSE:SEM)

Receive News & Ratings for Select Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Select Medical and related companies with MarketBeat.com's FREE daily email newsletter.